![Jason Mark Brooks](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Mark Brooks
Director/Board Member at
GYROSCOPE THERAPEUTICS HOLDINGS PLC
Profile
Jason Mark Brooks currently works at NeuTec Pharma Ltd., as Director from 2019, Novartis Pharmaceuticals UK Ltd., as Director from 2019, Sandoz Ltd., as Director from 2019, Vivacta Ltd., as Director from 2019, Novartis UK Ltd., as Director from 2019, Novartis Grimsby Ltd., as Director from 2019, Ziarco Pharma Ltd., as Director from 2019, Novartis Europharm Ltd., as Director from 2019, Oriel Therapeutics Ltd., as Director from 2019, and Gyroscope Therapeutics Holdings Plc, as Director from 2022.
Jason Mark Brooks active positions
| Companies | Position | Start |
|---|---|---|
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Director/Board Member | 2022-02-16 |
Novartis Pharmaceuticals UK Ltd.
 Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines and drugs | Director/Board Member | 2019-05-08 |
Novartis Grimsby Ltd.
 Novartis Grimsby Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Board Member | 2019-05-08 |
Sandoz Ltd.
 Sandoz Ltd. Pharmaceuticals: MajorHealth Technology Develops, produces and markets medicines | Director/Board Member | 2019-04-30 |
Novartis UK Ltd.
 Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets general medicines and pharmaceutical products | Director/Board Member | 2019-05-08 |
Novartis Europharm Ltd.
 Novartis Europharm Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Director/Board Member | 2019-04-30 |
NeuTec Pharma Ltd.
 NeuTec Pharma Ltd. BiotechnologyHealth Technology Develops biopharmaceutical products | Director/Board Member | 2019-04-30 |
Ziarco Pharma Ltd.
 Ziarco Pharma Ltd. BiotechnologyHealth Technology Provides therapeutics targeting inflammatory and allergic diseases | Director/Board Member | 2019-04-30 |
Oriel Therapeutics Ltd.
 Oriel Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Board Member | 2019-04-30 |
Former positions of Jason Mark Brooks
| Companies | Position | End |
|---|---|---|
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
17
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
NeuTec Pharma Ltd.
NeuTec Pharma Ltd. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Novartis Pharmaceuticals UK Ltd.
Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines and drugs | Health Technology |
Sandoz Ltd.
Sandoz Ltd. Pharmaceuticals: MajorHealth Technology Develops, produces and markets medicines | Health Technology |
Vivacta Ltd.
 Vivacta Ltd. Medical SpecialtiesHealth Technology Develops piezofilm-based chemical detection technology | Health Technology |
Novartis UK Ltd.
Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets general medicines and pharmaceutical products | Health Technology |
Novartis Grimsby Ltd.
Novartis Grimsby Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Ziarco Pharma Ltd.
Ziarco Pharma Ltd. BiotechnologyHealth Technology Provides therapeutics targeting inflammatory and allergic diseases | Health Technology |
Novartis Europharm Ltd.
Novartis Europharm Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Commercial Services |
Oriel Therapeutics Ltd.
Oriel Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Gyroscope Therapeutics Holdings Plc
 Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Develops clinical-stage gene therapies to treat diseases of eyes | Health Technology |
- Stock Market
- Insiders
- Jason Mark Brooks
